Repotrectinib
About
Therapy type: Targeted therapy
Therapy strategy: ROS inhibition
Mappings
NCI Thesaurus: Repotrectinib (ncit:C133821)
RxNorm: repotrectinib (rxcui:2670644, omop:747362)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | v::ROS1 | Non-Small Cell Lung Cancer | Repotrectinib | |
| EMA (1) FDA (1) | v::NTRK1 | Any solid tumor | Repotrectinib | |
| EMA (1) FDA (1) | v::NTRK2 | Any solid tumor | Repotrectinib | |
| EMA (1) FDA (1) | v::NTRK3 | Any solid tumor | Repotrectinib |